Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03169023 · ClinicalTrials.gov registry record · NA

Scale Down for Endometrial Cancer

A NA study of Endometrial Cancer and Cancer of the Endometrium, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
155
Enrollment target
1
Study location

NCT03169023 is a NA study of Endometrial Cancer and Cancer of the Endometrium that has completed, run by Washington University School of Medicine. The registered enrollment target is 155 participants, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03169023, a NA study of Endometrial Cancer and Cancer of the Endometrium, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
155 participants
Enrollment target
1
Study location

Study Summary

This proposal will pilot a weight management program for patients with endometrial cancer, the cancer most associated with obesity. If successful, this pilot could be expanded to include obese women with other gynecologic cancers (ovarian and cervical) and could be expanded and adapted for use not only upon completion of treatment, but during chemotherapy or radiation. Furthermore, other obstetricians and gynecologists could use this strategy for obese women as a practical cancer prevention strategy for obesity-associated cancers.

Interventions

  • BEHAVIORAL ScaleDown
  • BEHAVIORAL Enhanced Usual Care Packets
  • OTHER 12-Item Short Form Health Survey
  • OTHER International Physical Activity Questionnaire short form
  • OTHER Multidimensional Body Self Relations Questionnaire - Appearance Subscales

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 155 participants
Start Date 2017-02-21
Est. Completion 2019-02-03
Phase NA

What the Registry Record Tells You About NCT03169023

The ClinicalTrials.gov registry entry for NCT03169023 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (70% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Endometrial Cancer appearing as the primary indexed condition, and to 5 interventions - of which ScaleDown is the first listed.

NCT03169023 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT03169023 about?

NCT03169023 is a clinical study titled "Scale Down for Endometrial Cancer". This proposal will pilot a weight management program for patients with endometrial cancer, the cancer most associated with obesity. If successful, this pilot could be expanded to include obese women with other gynecologic cancers (ovarian and cervical) and could be expanded and adapted for use not o...

What is the current status of trial NCT03169023?

This trial is currently completed. It is a NA study. The enrollment target is 155 participants. The study started on 2017-02-21. Estimated completion is 2019-02-03.

What conditions does trial NCT03169023 study?

This clinical trial studies the following conditions: Endometrial Cancer, Cancer of the Endometrium.

What interventions are being tested in trial NCT03169023?

The interventions under investigation include: ScaleDown (BEHAVIORAL), Enhanced Usual Care Packets (BEHAVIORAL), 12-Item Short Form Health Survey (OTHER), International Physical Activity Questionnaire short form (OTHER), Multidimensional Body Self Relations Questionnaire - Appearance Subscales (OTHER).

Who is sponsoring clinical trial NCT03169023?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03169023 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Endometrial Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.